Biology

The Alaska SeaLife Center is a non-profit marine science facility dedicated to understanding and maintaining the integrity of the marine ecosystem of Alaska through research, rehabilitation and public education. The Center's research and rehabilitation facilities and naturalistic exhibits immerse visitors in the dynamic marine ecosystems of Alaska.

The Josephine Bay Paul Center for Comparative Molecular Biology and Evolution was officially established at the Marine Biological Laboratory in January of 1997. RESEARCH at the Center explores the evolution and interaction of genomes of diverse organisms that play significant roles in environmental biology and human health. Projects span all evolutionary time scales, from deep phylogenetic divergence of ancestral prokaryotic and eukaryotic lineages to ecological analyses of how members of diverse communities contribute and respond to environmental change. The Center is part of the Brown University - Marine Biological Laboratory Graduate Program in Biological and Environmental Sciences.

BioDiversity Research Institute (BRI) is a small, Maine-based nonprofit group dedicated to progressive environmental research and education. Our specialty is avian (bird) studies, and aquatic toxicology. We believe loons and other piscivorous (fish-eating) birds that are high in the food chain are the best indicators of their aquatic environment's condition. See the BRI bird cams and watch bald eagles, peregrine falcons, loons, and osprey live online.

The Rocky Mountain Biological Laboratory

The goal of the Biology and Biotechnology Research Program at Lawrence Livermore National Laboratory is to enhance the nations health and security through innovative multidisciplinary research in genomics, molecular biochemistry, and biotechnology. Program objectives include understanding genetic and biochemical causes of disease, countering biological terrorism, and developing and applying computational biology capabilities using the Laboratorys massively parallel computing resources. The program is also a founding partner in DOEs Joint Genome Institute in Walnut Creek, California.

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.

As the drug discovery and development arm of the National Cancer Institute, the Developmental Therapeutics Program (DTP) plans, conducts, and facilitates development of therapeutic agents for cancer and AIDS. We are your resource for research materials, including Web-accessible data and tools, vialed and plated compounds, tumor cells, animals, and Investigational New Drug (IND)-directed studies.

The EMBL-EBI lies in the 55 acres of landscaped parkland in rural Cambridgeshire that make up the Wellcome Trust Genome Campus. As we move towards understanding biology at the systems level, access to large data sets of many different types has become crucial. Technologies such as genome-sequencing, microarrays, proteomics and structural genomics have provided

Located on Torrey Pines Mesa in La Jolla, California, The Neurosciences Institute is a not-for-profit research center dedicated to "high risk - high payoff" research designed to discover the biological basis of higher-level brain functions in humans. The Neurosciences Institute was established in 1981 by Nobel Laureate Gerald M. Edelman, M.D., Ph.D., the current director. The Institute is unique in that it is supported entirely by private donations, intentionally small, group-oriented, interdisciplinary; and engaged in both theoretical and experimental neurobiology. Institute scientists have been responsible for many important discoveries involving consciousness, sleep, perception, music, memory, movement, behavior, and speech.

Since its founding in 1947, Dana-Farber has been committed to providing cancer patients with the best treatment available today while developing tomorrow's cures through cutting-edge research. The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases.

The National Center for Biomedical Ontology is a consortium of leading biologists, clinicians, informaticians, and ontologists who develop innovative technology and methods that allow scientists to create, disseminate, and manage biomedical information and knowledge in machine-processable form. Our vision is that all biomedical knowledge and data are disseminated on the Internet using principled ontologies, such that the knowledge and data are semantically interoperable and useful for furthering biomedical science and clinical care. The Center

The Gene Ontology (GO) project is a collaborative effort to address the need for consistent descriptions of gene products in different databases. The project began as a collaboration between three model organism databases, FlyBase (Drosophila), the Saccharomyces Genome Database (SGD) and the Mouse Genome Database (MGD), in 1998. Since then, the GO Consortium has grown to include many databases, including several of the world's major repositories for plant, animal and microbial genomes.

The International HapMap Project is a multi-country effort to identify and catalog genetic similarities and differences in human beings. Using the information in the HapMap, researchers will be able to find genes that affect health, disease, and individual responses to medications and environmental factors. The goal of the International HapMap Project is to compare the genetic sequences of different individuals to identify chromosomal regions where genetic variants are shared. By making this information freely available, the Project will help biomedical researchers find genes involved in disease and responses to therapeutic drugs. The Project is a collaboration among scientists and funding agencies from Japan, the United Kingdom, Canada, China, Nigeria, and the United States. All of the information generated by the Project will be released into the public domain.

CAMBIA is an international, independent non-profit research institute. For more than a decade, CAMBIA has been creating new tools to foster innovation and a spirit of collaboration in the life sciences. These tools are aimed at enabling people in disadvantaged communities and developing countries to choose their own methods, to help themselves meet their own challenges in food security, health, and natural resource management.

The Institute of Molecular Biophysics (IMB) is a multi-disciplinary institute consisting of faculty and their research groups who use biophysical, biochemical and computational tools to probe the structure, function, and dynamic properties of large molecules and macromolecular assemblies.

The TCBG brings the most advanced molecular modeling, bioinformatics, and computational technologies to bear on questions of biomedical relevance. We extend, refine and deliver these technologies in response to experimental progress and emerging needs of the wide biomedical research community. We magnify the impact of our work through direct collaboration with experimental researchers, the distribution of cutting-edge and user-friendly software, and via extensive training, service, and dissemination efforts. The Theoretical and Computational Biophysics Group (TCBG), an NIH Resource for Macromolecular Modeling and Bioinformatics, was founded by Professor Klaus Schulten in 1989 and is located at the Beckman Institute of the University of Illinois at Urbana-Champaign (UIUC).

The mission of Burnham Institute for Medical Research is to conduct world-class collaborative research to cure human disease, improve quality of life, and thus create a legacy for its employees, partners, donors and community. The Institute conducts basic biomedical research and our philosophy is grounded in the recognition that most breakthroughs in fighting human disease come from basic scientific investigations. Moreover, the emphasis on basic research, as opposed to clinically applied research, means that Institute discoveries often reveal fundamental concepts and principles of cell biology that have broad relevance in a number of diseases. Our research activities take place in nine buildings geographically located in the heart of San Diego

The Yale Institute for Biospheric Studies (YIBS) serves as a principal focus for Yale University's research and training efforts in the environmental sciences, and is committed to the teaching of environmental studies to future generations. It provides physical and intellectual centers for research and education that address fundamental questions that will inform the ability to generate solutions to the biosphere's most critical environmental solutions. The Institute was created in May, 1990 with an endowment from Mr. Edward P. Bass.

The mission of WaNPRC is to provide the appropriate environment to support outstanding biomedical research directed towards significant human health issues and nonhuman primate health and biology. To meet this mission, the WaNPRC supports biomedical research activities, professional research staff, specifically bred and maintained nonhuman primate colonies, and dedicated facilities and equipment required for nonhuman primate research protocols.

At a time when the world faces numerous public health crises, scientists at the New England Regional Primate Research Center (NERPRC) are extending the boundaries of research, making discoveries that will lead to better diagnosis, prevention, and treatment of human disease. Investigators in the Center's Divisions of Comparative Pathology, Immunology, Microbiology, Tumor Virology, and Primate Medicine are studying the mechanisms of immune destruction in AIDS, the development of AIDS vaccines, and the pathogenesis of viral-induced cancers. Their colleagues in the Divisions of Behavioral Biology and Neurochemistry are breaking new ground in our understanding and treatment of drug addiction, neuropsychiatric disorders, and Parkinson's disease. On this site you will learn more about the Center's diverse research programs and its exciting opportunities for collaboration and training.